Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
Crossref DOI link: https://doi.org/10.1007/s00280-014-2471-3
Published Online: 2014-05-11
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Yi
Wang, Jian
Li, Ke
Zhang, Li
Ren, Hongcan
Guo, Lixia
Sai, Yang
Zhang, Weihan
Su, Weiguo
Text and Data Mining valid from 2014-05-11